<!doctype html>
<html>
    <head>
        <meta charset="utf-8">
        <meta name="viewport" content="width=device-width, initial-scale=1">
        <title>Langerhans Cell Histiocytosis: A Review with Focus on Musculoskeletal Manifestations</title>
        <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/reveal.js@4.6.0/dist/reveal.css">
        <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/reveal.js@4.6.0/dist/theme/black.css" id="theme">
        <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/reveal.js@4.6.0/plugin/highlight/monokai.css">
        <!-- Your custom styles remain unchanged -->
        <style>
        .reveal .slides {
            text-align: left;
        }
        .reveal h1, .reveal h2, .reveal h3 {
            text-transform: none;
            text-align: center;
            margin-bottom: 10px; /* Reduce space below headings */
        }
        .reveal h2 {
            font-size: 1.5em; /* Slightly smaller h2 to save space */
            margin-top: 5px;
        }
        .reveal img {
            max-height: 450px; /* Slightly reduced from 500px */
            margin: 0 auto;
            display: block;
        }
        .image-row {
            display: flex;
            justify-content: space-around;
            align-items: center;
            margin-bottom: 5px; /* Reduce space below image rows */
        }
        .image-row img {
            max-height: 380px; /* Slightly reduced from 400px */
            margin: 5px; /* Reduced from 10px */
        }
        /* New styles for slides with images */
        section:has(img) ul {
            font-size: 0.75em; /* Slightly smaller text */
            margin-top: 5px; /* Reduced from 10px */
            padding-left: 20px; /* Reduce left padding of lists */
        }
        section:has(.image-row) ul {
            font-size: 0.75em;
            margin-top: 5px;
            padding-left: 20px;
        }
        section:has(img) li {
            margin-bottom: 0.2em; /* Reduced from 0.3em */
            line-height: 1.2; /* Tighter line height */
        }
        section:has(.image-row) li {
            margin-bottom: 0.2em;
            line-height: 1.2;
        }
        /* Fallback for browsers that don't support :has */
        .smaller-text ul {
            font-size: 0.75em;
            margin-top: 5px;
            padding-left: 20px;
        }
        .smaller-text li {
            margin-bottom: 0.2em;
            line-height: 1.2;
        }
        .attribution {
            font-size: 0.65em; /* Slightly smaller */
            font-style: italic;
            text-align: center;
            margin-top: 2px; /* Reduced from 5px */
            margin-bottom: 2px;
            color: #aaa;
        }
        /* Compact layout for slides with images and attribution */
        .compact-slide h2 {
            margin-bottom: 5px;
        }
        .compact-slide .image-row {
            margin-bottom: 2px;
        }
        .compact-slide .attribution {
            margin-top: 1px;
            margin-bottom: 1px;
        }
        /* Adjust vertical spacing in reveal.js */
        .reveal .slides section {
            padding: 0;
        }
        
        /* Modal styles */
        /* Removed Modal Styles */
        
        /* Adjust vertical spacing in reveal.js */
        .reveal .slides section {
            padding: 0;
        }
        
    </style>
</head>
<body>
    <div class="reveal">
        <div class="slides">
            <!-- Slide 1: Title -->
            <section>
                <h1>Interesting Case Conference</h1>
                <h3>Langerhans Cell Histiocytosis</h3>
                <p style="text-align: center;">Daniel Hofstedt, DO</p>
                <p style="text-align: center;">Tuesday, March 11, 2025</p>
            </section>

            <!-- Slide 2: Case Presentation -->
            <section>
                <h2>Case Presentation</h2>
                <ul>
                    <li>11-year-old female with persistent left thigh pain for several months in 2023</li>
                    <li>Initially diagnosed as "growing pains" but developed limping by November 2023</li>
                    <li>Medical history: IgA deficiency, eczema, ADHD, anxiety</li>
                </ul>
            </section>

            <!-- Slide 3: Initial Imaging -->
            <section class="smaller-text compact-slide">
                <h2>Initial Imaging</h2>
                <div class="image-row">
                    <img src="images/image1.png" alt="Anteroposterior (AP) radiograph showing a well-circumscribed lucent lesion in the left femoral diaphysis" data-description="AP radiograph of left femur">
                    <img src="images/image2.png" alt="Lateral radiograph illustrating a narrow zone of transition with surrounding periosteal reaction in the left femur" data-description="Lateral radiograph of left femur">
                </div>
                <ul>
                    <li>Well-circumscribed lucent lesion in the femoral diaphysis</li>
                    <li>Narrow zone of transition with surrounding periosteal reaction</li>
                </ul>
            </section>

            <!-- Slide 4: Advanced Imaging - MRI -->
            <section class="smaller-text compact-slide">
                <h2>Advanced Imaging - MRI</h2>
                <div class="image-row">
                    <img src="images/image5.png" alt="Coronal T1-weighted MRI showing a heterogeneous lesion in the mid to distal left femoral diaphysis" data-description="Coronal T1 MRI">
                    <img src="images/image6.png" alt="Coronal STIR MRI highlighting extensive reactive changes in the surrounding medullary canal" data-description="Coronal STIR MRI">
                    <img src="images/image8.png" alt="Post-contrast MRI demonstrating periosteal new bone formation with mild expansion" data-description="Post-contrast MRI">
                </div>
                <ul>
                    <li>Heterogeneous lesion involving mid to distal left femoral diaphysis</li>
                    <li>Extensive reactive changes in surrounding medullary canal</li>
                    <li>Periosteal new bone formation with mild expansion</li>
                </ul>
            </section>

            <!-- Slide 5: Biopsy Findings -->
            <section class="smaller-text compact-slide">
                <h2>Biopsy Findings</h2>
                <div style="text-align: center;">
                    <img src="images/image10.png" alt="CT-guided biopsy image showing the procedure performed in December 2023 for Langerhans cell histiocytosis" data-description="CT-guided biopsy">
                </div>
                <ul>
                    <li>CT-guided biopsy performed December 2023</li>
                    <li>Pathology: Positive for Langerhans cell histiocytosis</li>
                    <li>IHC: Positive for CD1a, langerin, and S100; BRAF negative</li>
                </ul>
            </section>

            <!-- Slide 6: Follow-up PET/CT -->
            <section class="smaller-text compact-slide">
                <h2>Follow-up PET/CT</h2>
                <div class="image-row">
                    <img src="images/image11.png" alt="Initial PET/CT scan from February 2024 showing SUVmax of 3.3 in the left femoral lesion" data-description="Initial PET/CT">
                    <img src="images/image12.png" alt="Follow-up PET/CT scan from May 2024 showing decreased uptake (SUVmax 1.7) in the left femoral lesion" data-description="Follow-up PET/CT">
                </div>
                <ul>
                    <li>Initial PET (2/2024): SUVmax 3.3 in left femoral lesion</li>
                    <li>Follow-up PET (5/2024): Decreased uptake (SUVmax 1.7) and extent</li>
                    <li>Most recent PET (12/2024): No evidence of residual/recurrent disease</li>
                </ul>
            </section>

            <!-- Slide 7: What is Langerhans Cell Histiocytosis? -->
            <section>
                <h2>What is Langerhans Cell Histiocytosis?</h2>
                <ul>
                    <li>Proliferation of dendritic cells resembling Langerhans cells</li>
                    <li>Characterized by CD1a, S100, and CD207 (langerin) expression</li>
                    <li>Birbeck granules on electron microscopy (racquet-shaped organelles)</li>
                </ul>
            </section>

            <!-- Slide 8: Classification of LCH -->
            <section>
                <h2>Classification of LCH</h2>
                <ul>
                    <li>Unifocal (localized): Single bone/few bones (~70% of cases)</li>
                    <li>Multifocal unisystem: Multiple bones and/or other single system (~20%)</li>
                    <li>Multifocal multisystem: Disseminated involvement of multiple systems (~10%)</li>
                </ul>
            </section>

            <!-- Slide 9: Epidemiology and Clinical Presentation -->
            <section>
                <h2>Epidemiology and Clinical Presentation</h2>
                <ul>
                    <li>Most common in children 1-3 years; can occur at any age</li>
                    <li>Male predominance (M:F = 2:1)</li>
                    <li>Presentation varies by site of involvement:
                        <ul>
                            <li>Bone pain and swelling (most common)</li>
                            <li>Skin rash</li>
                            <li>Diabetes insipidus (pituitary involvement)</li>
                        </ul>
                    </li>
                </ul>
            </section>

            <!-- Slide 10: Musculoskeletal Manifestations - Skeletal Distribution -->
            <section>
                <h2>Musculoskeletal Manifestations</h2>
                <h3>Skeletal Distribution</h3>
                <ul>
                    <li>Occurs in ~80% of LCH patients</li>
                    <li>Common sites:
                        <ul>
                            <li>Skull (most common)</li>
                            <li>Long bones (femur, humerus, tibia)</li>
                            <li>Pelvis</li>
                            <li>Spine</li>
                            <li>Ribs</li>
                            <li>Mandible</li>
                        </ul>
                    </li>
                </ul>
            </section>

            <!-- Slide 11: Skull Lesions -->
            <section class="smaller-text compact-slide">
                <h2>Skull Lesions</h2>
                <div class="image-row">
                    <img src="images/zaveri-skull-punched-out-lesion.png" alt="Punched-out skull lesion" data-description="Punched-out skull lesion">
                    <img src="images/zaveri-geographic-skull.png" alt="Geographic skull appearance" data-description="Geographic skull appearance">
                </div>
                <p class="attribution">Zaveri J, et al. Radiographics 2014</p>
                <ul>
                    <li>"Punched-out" lytic lesions with beveled edges</li>
                    <li>Geographic skull appearance when lesions coalesce</li>
                    <li>Key teaching point: Lack of periosteal reaction in calvarial lesions</li>
                </ul>
            </section>

            <!-- Slide 12: Long Bone Lesions -->
            <section class="smaller-text compact-slide">
                <h2>Long Bone Lesions</h2>
                <div class="image-row">
                    <img src="images/image1.png" alt="Anteroposterior (AP) radiograph showing a well-circumscribed lucent lesion in the left femoral diaphysis" data-description="Our case">
                    <img src="images/companion-case-1.png" alt="Companion case" data-description="Companion case">
                </div>
                <ul>
                    <li>Diaphyseal or metaphyseal predilection</li>
                    <li>Early: Lytic, expansile, aggressive appearance</li>
                    <li>Later: Sclerotic margin develops (chronic lesions)</li>
                    <li>Unlike skull lesions, periosteal reaction is common</li>
                </ul>
            </section>

            <!-- Slide 13: Spine Involvement -->
            <section class="smaller-text compact-slide">
                <h2>Spine Involvement</h2>
                <div style="text-align: center;">
                    <img src="images/zaveri-coronal-ct-spine.png" alt="Spine involvement" data-description="Spine involvement">
                </div>
                <p class="attribution">Zaveri J, et al. Radiographics 2014</p>
                <ul>
                    <li>Classic finding: Vertebra plana</li>
                    <li>Symmetric, uniform collapse of vertebral body</li>
                    <li>Preserved intervertebral disk spaces</li>
                </ul>
            </section>

            <!-- Slide 14: Differential Diagnosis - Solitary Bone Lesions -->
            <section>
                <h2>Differential Diagnosis</h2>
                <h3>Solitary Bone Lesions</h3>
                <ul>
                    <li>Langerhans Cell Histiocytosis</li>
                    <li>Osteomyelitis/Brodie's abscess</li>
                    <li>Eosinophilic granuloma (subset of LCH)</li>
                    <li>Fibrous dysplasia</li>
                    <li>Simple bone cyst</li>
                    <li>Aneurysmal bone cyst</li>
                </ul>
            </section>

            <!-- Slide 15: Extraskeletal Manifestations - Brief Overview -->
            <section>
                <h2>Extraskeletal Manifestations</h2>
                <h3>Brief Overview</h3>
                <ul>
                    <li>CNS: Pituitary stalk thickening → diabetes insipidus</li>
                    <li>Pulmonary: Nodules → cysts (predominantly upper lobes)</li>
                    <li>Skin: Seborrheic-like rash, xanthomatous lesions</li>
                    <li>Liver/spleen: Organomegaly, sclerosing cholangitis</li>
                    <li>Lymph nodes: Cervical lymphadenopathy</li>
                </ul>
            </section>

            <!-- Slide 16: Pathologic Features -->
            <section>
                <h2>Pathologic Features</h2>
                <ul>
                    <li>Proliferation of Langerhans cells with grooved/folded nuclei</li>
                    <li>Admixed eosinophils, lymphocytes, neutrophils</li>
                    <li>Diagnostic markers:
                        <ul>
                            <li>CD1a+</li>
                            <li>Langerin (CD207)+</li>
                            <li>S100+</li>
                            <li>BRAF V600E mutation in ~50% of cases</li>
                        </ul>
                    </li>
                </ul>
            </section>

            <!-- Slide 17: Treatment and Prognosis -->
            <section>
                <h2>Treatment and Prognosis</h2>
                <ul>
                    <li>Unifocal disease: Often observation alone or local therapy</li>
                    <li>Multifocal/multisystem: Systemic chemotherapy ± steroids</li>
                    <li>Our patient: Good response with resolution of metabolic activity</li>
                    <li>Prognosis:
                        <ul>
                            <li>Excellent for unifocal osseous disease (>90% survival)</li>
                            <li>Guarded for multisystem disease with risk organ involvement</li>
                        </ul>
                    </li>
                </ul>
            </section>

            <!-- Slide 18: Key Teaching Points -->
            <section>
                <h2>Key Teaching Points</h2>
                <ul>
                    <li>"Punched-out" skull lesions with beveled edges are pathognomonic</li>
                    <li>Vertebra plana = think LCH in children</li>
                    <li>Periosteal reaction present in long bone lesions, absent in skull</li>
                    <li>Classic triad: Lytic bone lesions + exophthalmos + diabetes insipidus</li>
                </ul>
            </section>

            <!-- Slide 19: Diagnostic Approach for Suspected Histiocytic Disorders -->
            <section class="smaller-text compact-slide">
                <h1 style="font-size: 36px;">Diagnostic Approach for Suspected Histiocytic Disorders</h1>
                <div style="text-align: center;">
                    <img src="images/goyal-paper-lch-dx-flowcart.jpg" alt="Diagnostic flowchart" data-description="Diagnostic flowchart">
                </div>
                <p class="attribution">Goyal G, et al. Mayo Clin Proc 2019</p>
                <ul>
                    <li>Initial evaluation: Whole-body PET-CT, labs, biopsy</li>
                    <li>Role of BRAF V600E testing</li>
                </ul>
            </section>

            <!-- Slide 20: Summary -->
            <section>
                <h2>Summary</h2>
                <ul>
                    <li>Langerhans Cell Histiocytosis has variable clinical manifestations</li>
                    <li>Classic imaging appearance depends on anatomic location</li>
                    <li>Unifocal disease has excellent prognosis</li>
                    <li>Our patient shows complete metabolic response on follow-up</li>
                </ul>
            </section>

            <!-- Slide 21: References -->
            <section>
                <h2>References</h2>
                <ul>
                    <li style="font-size: 26px;">Goyal G, Young JR, Koster MJ, Tobin WO, Vassallo R, Ryu JH, Davidge-Pitts CJ, Hurtado MD, Ravindran A, Sartori Valinotti JC, Bennani NN, Shah MV, Rech KL, Go RS; Mayo Clinic Histiocytosis Working Group. The Mayo Clinic Histiocytosis Working Group Consensus Statement for the Diagnosis and Evaluation of Adult Patients With Histiocytic Neoplasms: Erdheim-Chester Disease, Langerhans Cell Histiocytosis, and Rosai-Dorfman Disease. Mayo Clin Proc. 2019 Oct;94(10):2054-2071. doi: 10.1016/j.mayocp.2019.02.023. Epub 2019 Aug 28. PMID: 31472931.</li>
                    <li style="font-size: 26px;">Zaveri J, La Q, Yarmish G, Neuman J. More than just Langerhans cell histiocytosis: a radiologic review of histiocytic disorders. Radiographics. 2014 Nov-Dec;34(7):2008-24. doi: 10.1148/rg.347130132. PMID: 25384298.</li>
                </ul>
            </section>

            <!-- Slide 22: Thank You -->
            <section>
                <h2>Thank You</h2>
                <p style="text-align: center;">Questions?</p>
            </section>
        </div>
    </div>

    <script src="https://cdn.jsdelivr.net/npm/reveal.js@4.6.0/dist/reveal.js"></script>
    <script src="https://cdn.jsdelivr.net/npm/reveal.js@4.6.0/plugin/markdown/markdown.js"></script>
    <script src="https://cdn.jsdelivr.net/npm/reveal.js@4.6.0/plugin/highlight/highlight.js"></script>
    <script src="https://cdn.jsdelivr.net/npm/reveal.js@4.6.0/plugin/notes/notes.js"></script>
    <script src="https://cdn.jsdelivr.net/npm/reveal.js@4.6.0/plugin/zoom/zoom.js"></script>
    <script>
        Reveal.initialize({
            hash: true,
            plugins: [ RevealMarkdown, RevealHighlight, RevealNotes, RevealZoom ]
        });
    </script>
</body>
</html>
